RETA INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals, Inc.

Posted on by

NEW YORK, May 25, 2023 /PRNewswire/ — Levi & Korsinsky notifies investors that it has commenced an investigation of Reata Pharmaceuticals, Inc. (“Reata” or “the Company”) (NASDAQ: RETA): concerning possible violations of federal securities laws. On May 10, 2023, Reata issued a press…